$10.75
+0.24 (+2.28%)
Open$11.01
Previous Close$10.51
Day High$11.01
Day Low$10.42
52W High$12.54
52W Low$9.67
Volume—
Avg Volume622.1K
Market Cap313.64M
P/E Ratio35.36
EPS$0.30
SectorN/A
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 135.08M | 121.63M | 118.56M |
| Net Income | 17.61M | 16.33M | 12.40M |
| Profit Margin | 13.0% | 13.4% | 10.5% |
| EBITDA | 24.03M | 20.66M | 18.77M |
| Free Cash Flow | 10.51M | 10.54M | 10.38M |
| Rev Growth | +23.9% | -5.2% | +1.5% |
| Debt/Equity | 0.47 | 0.37 | 0.44 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.03 | +34.07% | — | 1.41B |
| PICS | Pics Nv | $11.49 | +0.70% | 6.6 | 1.48B |
| DMII | Drugs Made In America Acquis | $10.13 | +0.10% | 75.2 | 645.28M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.75 | +0.55% | 35.5 | 336.67M |
| CEPF | Cantor Equity Partners-Cl A | $10.39 | +0.14% | 57.9 | 595.50M |